Researchers from Astrazeneca plc recently reported preclinical data for AZD-3470, a second-generation MTA-cooperative PRMT5 inhibitor currently in early clinical development for the treatment of ...

A race after running into a 'TDN Rising Star' at Keeneland, Quantum Burst will now be the running line for many horses after she overwhelmed this maiden field to take home her own TDN Stamp of ...